This feature highlights changes in clinical trial organizations’ personnel.
Carla Poulson has been hired as senior vice president and chief human resources officer at Akcea Therapeutics. Poulson was most recently vice president and senior human resources business partner at Vertex Pharmaceuticals.
Amylyx Pharmaceuticals has appointed Machelle Manuel vice president and head of global medical affairs. Manuel was head of global medical scientific affairs at Ironwood Pharmaceuticals prior to joining Amylyx.
Joseph Lobacki has been appointed CEO of autoimmune disease company Artax Biopharma. Most recently, Lobacki was executive vice president of commercial and medical affairs at Verastem Oncology.
Gene therapy biotech Aruvant Sciences has appointed Joseph McIntosh chief medical officer. McIntosh was most recently vice president and head of clinical development at PTC Therapeutics.
Joseph Truitt, the interim CEO of BioSpecifics, has been named CEO of the company.
Caribou Biosciences has appointed Cherry Thomas senior vice president of clinical development. Thomas served as vice president of clinical development at Array Biopharma prior to this new role.
Celsius Therapeutics has found its newest chief scientific officer in Jeanne Magram, who was most recently chief scientific officer of Quentis Therapeutics.
Tapan Maniar, former vice president of clinical development at Repertoire Immune Medicines, has been appointed senior vice president and head of clinical development at Dragonfly Therapeutics.
Debra Feldman, who most recently led regulatory affairs at Sage Therapeutics, has been appointed vice president and head of regulatory at Dyne Therapeutics.
FogPharma has named Tony Gibney chief financial officer and chief business officer. Gibney recently served as executive vice president and chief business officer of Achillion.
Marc Uknis has been named chief medical officer of Gemini Therapeutics. Uknis was most recently vice president and global nephrology development lead at Achillion.
Genentech has hired Aviv Regev, a former core institute member of the Broad Institute of MIT and Harvard, to head the biotech’s research and early development division.
Craig Cook has been named CEO of Herantis Pharma. Formerly, Cook was CEO of UK-based Midatech Pharma.
Kim Sablich has been named executive vice president and general manager of North America at Jazz Pharmaceuticals. Previously, Sablich was chief commercial officer at Myovant Sciences.
Patrick Bergstedt will now serve as senior vice president for commercial vaccines at Moderna. Most recently, Bergstedt was head of global marketing and commercial operations for vaccines at Merck. Moderna has also named Jacqueline Miller senior vice president of infectious disease development. Miller was previously vice president and head of clinical R&D at GlaxoSmithKline. Additionally, Moderna has appointed Charbel Haber senior vice president of regulatory affairs. Haber joins Moderna from Biogen, where he served as vice president of global safety and regulatory sciences.
Myst Therapeutics has appointed George Smith vice president of business operations. Smith was founder and most recently the integrated program lead as well as senior director at IQVIA’s Gene Therapy Center.
Oligomerix has appointed Robert Foerster chief financial officer. Foerster held several roles at Pfizer for 28 years prior to joining Oligomerix.
Donald Manning has been named chief medical officer of Pacira Biosciences. Prior to this appointment, Manning was chief medical officer of Adynxx.
BridgeBio Pharma’s Phoenix Tissue Repair has named Hal Landy its chief medical officer. Landy was most recently chief medical officer at 4s3 Bioscience. Also, Deborah Ramsdell was named chief operating officer of Phoenix, joining the company from her previous position as consultant president/CEO of Valerion Therapeutics.
Gabriella Camboni has been named CEO of Milan-based dermatologic biotech PinCell. Camboni is also CEO of BiovelocITA.
Spirovant Sciences has tapped Roland Kolbeck for the role of chief scientific officer. Kolbeck was most recently vice president and head of respiratory, inflammation and autoimmune research at MedImmune.
Dasharatha Reddy, former head of CMC at Landos Biopharma, will now serve as vice president of pharmaceutical development and manufacturing at Spruce Biosciences.
Owen O’Connor has been named chief scientific officer of TG Therapeutics. O’Connor is professor of medicine and experimental therapeutics at Columbia University Medical Center.
Dan Mosher has been named VuMedi’s chief operating officer. Mosher joins VuMedi from Postmates, where he served as senior vice president and merchant lead.
Wellcome Leap, a not-for-profit organization that funds global health innovations, has named Regina Dugan as CEO. Dugan most recently held the position of vice president at Facebook’s Building 8.